Eleonora Alma

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Classical Hodgkin Lymphoma Today.

Classical Hodgkin Lymphoma Today.

Journal: Mediterranean journal of hematology and infectious diseases

Published: May 12, 2026

Treatment outcomes in elderly patients ≥ 65 years with Large B-Cell Lymphoma (LBCL): a real-world single center experience focusing on potential CD19-CAR-T eligibility in second line.

Treatment outcomes in elderly patients ≥ 65 years with Large B-Cell Lymphoma (LBCL): a real-world single center experience focusing on potential CD19-CAR-T eligibility in second line.

Journal: Annals of hematology

Published: April 11, 2025

Predicting thrombotic risk in patients with classical Hodgkin lymphoma: Thro-HL multicenter study.

Predicting thrombotic risk in patients with classical Hodgkin lymphoma: Thro-HL multicenter study.

Journal: HemaSphere

Published: February 04, 2025

The Impact of Radiotherapy and Attenuated Chemotherapy Regimens in Older Patients with Classic Hodgkin Lymphoma: A Real-Life Study from the ReLLi Network.

The Impact of Radiotherapy and Attenuated Chemotherapy Regimens in Older Patients with Classic Hodgkin Lymphoma: A Real-Life Study from the ReLLi Network.

Journal: Cancers

Published: January 20, 2025

Heterogeneous Surface CD79b Expression in Aggressive B-Cell Lymphomas Assessed by Flow Cytometry on Lymph Node Biopsies.

Heterogeneous Surface CD79b Expression in Aggressive B-Cell Lymphomas Assessed by Flow Cytometry on Lymph Node Biopsies.

Journal: Cancers

Published: October 25, 2024

Baseline Tumor Burden Assessed With AI-Guided PET/CT Total Metabolic Tumor Volume (TMTV) and LDH Levels Predict Efficacy of CAR-T in Aggressive B-Cell Lymphoma.

Baseline Tumor Burden Assessed With AI-Guided PET/CT Total Metabolic Tumor Volume (TMTV) and LDH Levels Predict Efficacy of CAR-T in Aggressive B-Cell Lymphoma.

Journal: Hematological oncology

Published: October 16, 2024

Predicting therapy-related myeloid neoplasms after CAR-T with the Clonal Haematopoiesis Risk Score (CHRS).

Predicting therapy-related myeloid neoplasms after CAR-T with the Clonal Haematopoiesis Risk Score (CHRS).

Journal: British journal of haematology

Published: August 18, 2024

Novel Targets and Advanced Therapies in Diffuse Large B Cell Lymphomas.

Novel Targets and Advanced Therapies in Diffuse Large B Cell Lymphomas.

Journal: Cancers

Published: May 10, 2024

Risk of SARS-CoV-2 infection in patients with hematologic diseases receiving tixagevimab/cilgavimab as pre-exposure prophylaxis in most recent Omicron sublineages era.

Risk of SARS-CoV-2 infection in patients with hematologic diseases receiving tixagevimab/cilgavimab as pre-exposure prophylaxis in most recent Omicron sublineages era.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: February 13, 2024

Enhancing lymphoma diagnosis on core needle biopsies: Integrating immunohistochemistry with flow cytometry.

Enhancing lymphoma diagnosis on core needle biopsies: Integrating immunohistochemistry with flow cytometry.

Journal: Cytometry. Part B, Clinical cytometry

Published: January 23, 2024

Endoscopic Ultrasound-Guided Fine Needle Biopsy in the Diagnostic Work-Up of Deep-Seated Lymphadenopathies and Spleen Lesions: A Monocentric Experience.

Endoscopic Ultrasound-Guided Fine Needle Biopsy in the Diagnostic Work-Up of Deep-Seated Lymphadenopathies and Spleen Lesions: A Monocentric Experience.

Journal: Diagnostics (Basel, Switzerland)

Published: June 13, 2023

Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion.

Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion.

Journal: Hematological oncology

Published: December 28, 2022

Showing 1-12 of 31

Last Updated: 09/26/2026